Skip to main content
logo
Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
1.138
-0.042 (-3.56%)
May 15, 2026, 3:01 PM EDT - Market open

Sonoma Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Cap
74351216
Market Cap Growth
17.79%37.73%-46.06%-61.26%-20.04%78.54%
Enterprise Value
5.43.83-0.121.596.0413.77
Last Close Price
1.142.193.3319.5380.20148.60
PE Ratio
--0.78-0.31-0.64-2.09-3.77
PS Ratio
0.410.250.200.360.980.83
PB Ratio
0.580.810.420.601.432.90
P/TBV Ratio
0.550.620.250.421.222.77
P/FCF Ratio
--21.30-1.08-0.75-2.84-4.37
P/OCF Ratio
--40.67-1.08-0.78-2.93-4.60
EV/Sales Ratio
0.300.27-0.010.120.480.74
EV/EBITDA Ratio
--1.070.03-0.36-1.06-4.27
EV/EBIT Ratio
--1.030.03-0.35-1.03-3.99
EV/FCF Ratio
--22.770.05-0.25-1.38-3.87
Debt / Equity Ratio
0.150.060.070.070.110.45
Debt / EBITDA Ratio
-0.25-0.08-0.13-0.19-0.24-0.83
Debt / FCF Ratio
-0.18-1.81-0.25-0.13-0.31-0.75
Net Debt / Equity Ratio
0.190.07-0.41-0.37-0.69-0.29
Net Debt / EBITDA Ratio
-0.25-0.080.560.671.060.48
Net Debt / FCF Ratio
-0.18-1.811.050.461.380.43
Asset Turnover
1.301.010.820.760.751.26
Inventory Turnover
6.976.492.873.193.335.12
Quick Ratio
-01.621.721.681.72
Current Ratio
1.010.763.373.712.823.18
Return on Equity (ROE)
-85.04%-44.69%-74.07%-62.58%-81.79%-84.01%
Return on Assets (ROA)
-20.74%-21.16%-31.54%-26.22%-36.93%-19.08%
Return on Invested Capital (ROIC)
-30.20%-26.64%-52.99%-52.54%-79.04%-37.90%
Return on Capital Employed (ROCE)
-23.60%-30.36%-39.95%-35.79%-49.19%-33.26%
Earnings Yield
-46.11%-127.40%-319.22%-155.66%-47.88%-26.51%
FCF Yield
-50.89%-4.69%-92.36%-133.28%-35.26%-22.87%
Buyback Yield / Dilution
-60.61%-172.75%-168.12%-27.93%-32.92%-35.14%
Total Shareholder Return
-60.61%-172.75%-168.12%-27.93%-32.92%-35.14%
Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q